{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Chestnut Ridge",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80969",
      "recalling_firm": "Par Pharmaceutical, Inc.",
      "address_1": "1 Ram Ridge Rd",
      "address_2": "N/A",
      "postal_code": "10977-6714",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "United States nationwide",
      "recall_number": "D-1185-2018",
      "product_description": "Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11",
      "product_quantity": "16,207 (bottles of 30 tablets)",
      "reason_for_recall": "Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.",
      "recall_initiation_date": "20180906",
      "center_classification_date": "20180910",
      "termination_date": "20191206",
      "report_date": "20180919",
      "code_info": "Lot #: 29906202, Exp 12/18; 29993102, Exp 2/19; 30366102, 30373103, Exp 4/19; 31940601, Exp 3/20."
    }
  ]
}